DBV Technologies (NASDAQ:DBVT) Stock Passes Below 50-Day Moving Average – Time to Sell?

DBV Technologies S.A. (NASDAQ:DBVT)’s share price crossed below its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $3.37 and traded as low as $2.99. DBV Technologies shares last traded at $3.09, with a volume of 24,330 shares changing hands.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on the stock. StockNews.com started coverage on shares of DBV Technologies in a research report on Wednesday. They set a “hold” rating for the company. JMP Securities reissued a “market outperform” rating and issued a $10.00 target price on shares of DBV Technologies in a report on Tuesday, December 10th. Finally, HC Wainwright lifted their price target on DBV Technologies from $25.00 to $35.00 and gave the stock a “buy” rating in a research note on Thursday, October 24th.

DBV Technologies Trading Down 1.9 %

The firm has a market capitalization of $63.56 million, a PE ratio of -0.69 and a beta of 0.64. The stock’s 50 day moving average price is $3.37 and its two-hundred day moving average price is $3.88.

DBV Technologies Company Profile

DBV Technologies SA, a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed Phase 3 clinical trial for the treatment of peanut allergies; and Viaskin Milk which is in Phase 1/2 clinical trial for the treatment of immunoglobulin E (IgE) mediated or cow’s milk protein allergy and eosinophilic esophagitis.